Authors
Tihana Bicanic, Conrad Muzoora, Annemarie E Brouwer, Graeme Meintjes, Nicky Longley, Kabanda Taseera, Kevin Rebe, Angela Loyse, Joseph Jarvis, Linda-Gail Bekker, Robin Wood, Direk Limmathurotsakul, Wirongrong Chierakul, Kasia Stepniewska, Nicholas J White, Shabbar Jaffar, Thomas S Harrison
Publication date
2009/9/1
Journal
Clinical infectious diseases
Volume
49
Issue
5
Pages
702-709
Publisher
The University of Chicago Press
Description
Background . Progress in therapy for cryptococcal meningitis has been slow because of the lack of a suitable marker of treatment response. Previously, we demonstrated the statistical power of a novel endpoint, the rate of clearance of infection, based on serial quantitative cultures of cerebrospinal fluid, to differentiate the fungicidal activity of alternative antifungal drug regimens. We hypothesized that the rate of clearance of infection should also be a clinically meaningful endpoint.
Methods . We combined data from cohorts of patients with human immunodeficiency virus-associated cryptococcal meningitis from Thailand, South Africa, and Uganda, for whom the rate of clearance of infection was determined, and clinical and laboratory data prospectively collected, and explored the association between the rate of clearance of infection and mortality by Cox survival analyses …
Total citations
20092010201120122013201420152016201720182019202020212022202320241206222627201715181591013133